# Sanofi: Form 20-F for the period ended Dec 31, 2025

- Company: [Sanofi](/companies/sny.md) (CIK 1121404)
- Form: 20-F
- Filed: 2026-02-17
- Accepted by EDGAR: Feb 17, 2026, 12:34 ET
- Period: 2025-12-31
- Accession: 0001628280-26-008403
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1121404/000162828026008403/sny-20251231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1121404/000162828026008403/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 12 months, 2025-01-01 to 2025-12-31 | EUR 13.05bn | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2025-01-01 to 2025-12-31 | EUR 33.67bn | ifrs-full:GrossProfit |
| Operating income | 12 months, 2025-01-01 to 2025-12-31 | EUR 6.34bn | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2025-01-01 to 2025-12-31 | EUR 1.04bn | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | EUR 7.81bn | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2025-01-01 to 2025-12-31 | EUR 6.37 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2025-01-01 to 2025-12-31 | EUR 6.40 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2025-01-01 to 2025-12-31 | EUR 10.75bn | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Cash and equivalents | at 2025-12-31 | EUR 7.66bn | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2025-12-31 | EUR 30.95bn | ifrs-full:CurrentAssets |
| Total assets | at 2025-12-31 | EUR 126.81bn | ifrs-full:Assets |
| Current liabilities | at 2025-12-31 | EUR 28.34bn | ifrs-full:CurrentLiabilities |
| Shareholders' equity | at 2025-12-31 | EUR 71.38bn | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2025-12-31 | 1,219,427,096 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1121404/000162828026008403/sny-20251231.htm

Filed Feb 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-008403. Last ingested by Listed: Oct 30, 2026, 08:51 ET. No prices; not investment advice.